2024. EVALUATE THE CONCENTRATION OF SERUM CFDNA AND INTEGRITY AS A NON-INVASIVE MARKER TO DISTINGUISH BETWEEN MALIGNANT AND BENIGN BREAST LESION. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases. 31, 1 (Feb. 2024), 366–389.